← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Celldex Therapeutics, Inc.
Needham, MA
$8,060,033
Total funding
8
Grants
Funding over time
peak $2.1M · FY2005–21$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,060,033 · 8
By mechanism
R44$7,194,864 · 3
R43$555,243 · 3
N43$199,398 · 1
R41$110,528 · 1
Investigators at Celldex Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Immune modulation of radiation therapy with Flt3 ligand$1,631,702
R44 · FY2021 · CA
Immune modulation of radiation therapy with Flt3 ligand$1,204,513
R44 · FY2020 · CA
Immune modulation of radiation therapy with Flt3 ligand$1,081,749
R44 · FY2015 · CA
Dendritic Cell-Targeted HIV Vaccine Product$999,540
R44 · FY2014 · AI
Dendritic Cell-Targeted HIV Vaccine Product$988,487
R44 · FY2015 · AI
Development and cGMP Manufacture of a Vitrified Typhoid Vaccine$750,000
R44 · FY2006 · AI
Immune modulation of radiation therapy with Flt3 ligand$538,873
R44 · FY2016 · CA
Dendritic Cell-Targeted HIV Vaccine Product$297,572
R43 · FY2011 · AI
Immune modulation of radiation therapy with Flt3 ligand$199,398
N43 · FY2012 · CA
Live Attenuated Salmonella Vaccine Against Campylobacter$130,810
R43 · FY2005 · AI
Feasibility Evaluation of an Oral Typhoid Fever Vaccine$126,861
R43 · FY2003 · AI
CDX-301 and Plerixafor Combination in Stem Cell Mobilization for Transplantation$100,000
R41 · FY2013 · OD
CDX-301 and Plerixafor Combination in Stem Cell Mobilization for Transplantation$10,528
R41 · FY2013 · OD